Fig. 6
From: Lipid management in India: a nationwide, cross-sectional physician survey
Choice of pharmacotherapy for different patient profiles. Atherogenic dyslipidemia: LDL-C > 160 mg/dL, TG 200–499 mg/dL and HDL-C < 40 mg/dL without CHD or CHD risk equivalents. Moderate hypertriglyceridemia: TG 200–499 mg/dL with LDL-C levels at goal. Borderline high LDL-C: LDL-C 130–160 mg/dL and TG (<200 mg/dL) without CHD or CHD risk equivalents. CHD Coronary heart disease, HDL-C High density lipoprotein cholesterol, LDL-C low density lipoprotein cholesterol, TG triglycerides